Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monia Marchetti

Showing results (1-10 of 123) with videos related to

Pageof 13
Sort By:
Expert Review of Pharmacoeconomics & Outcomes Research|August 11, 2017
Cost-effectiveness of kinase inhibitors for hematologic malignancies: a systematic and critical reviewMonia Marchetti
Annals of Hematology|June 26, 2020
COVID-19-driven endothelial damage: complement, HIF-1, and ABL2 are potential pathways of damage and targets for cureMonia Marchetti
Expert Review of Medical Devices|November 19, 2005
Drug-eluting stents: from evidence to policyMonia Marchetti
Pharmacoeconomics|November 5, 2004
Clinical and economic impact of epoetins in cancer careMonia Marchetti, Giovanni Barosi
Expert Review of Pharmacoeconomics & Outcomes Research|September 30, 2014
Biological therapies in Crohn's disease: are they cost-effective? A critical appraisal of model-based analysesMonia Marchetti, Nicola Lucio Liberato
Expert Review of Pharmacoeconomics & Outcomes Research|January 29, 2016
Cost-effectiveness of non-vitamin K antagonist oral anticoagulants for stroke prevention in non-valvular atrial fibrillation: a systematic and qualitative reviewNicola Lucio Liberato, Monia Marchetti
Clinical Therapeutics|November 9, 2004
Cost utility and budget impact of third-generation aromatase inhibitors for advanced breast cancer: a literature-based model analysis of costs in the Italian National Health ServiceMonia Marchetti, Mauro Caruggi, Giorgio Colombo
Drugs & Aging|July 2, 2003
Clinical and economic issues in the treatment of advanced breast cancer with bisphosphonatesNicola Lucio Liberato, Monia Marchetti, Giovanni Barosi
Mediterranean Journal of Hematology and Infectious Diseases|May 19, 2021
Cost-Effectiveness of Post-Autotransplant Lenalidomide in Persons with Multiple MyelomaMonia Marchetti, Robert Peter Gale, Giovanni Barosi
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Cost minimization of on-demand maintenance therapy with proton pump inhibitors in nonerosive gastroesophageal reflux diseaseDyfrig A Hughes, Monia Marchetti, Giorgio Colombo
Pageof 13

Showing results (1-10 of 123) with videos related to

Sort By:
Pageof 13
Expert Review of Pharmacoeconomics & Outcomes Research|August 11, 2017
Cost-effectiveness of kinase inhibitors for hematologic malignancies: a systematic and critical reviewMonia Marchetti
Annals of Hematology|June 26, 2020
COVID-19-driven endothelial damage: complement, HIF-1, and ABL2 are potential pathways of damage and targets for cureMonia Marchetti
Expert Review of Medical Devices|November 19, 2005
Drug-eluting stents: from evidence to policyMonia Marchetti
Pharmacoeconomics|November 5, 2004
Clinical and economic impact of epoetins in cancer careMonia Marchetti, Giovanni Barosi
Expert Review of Pharmacoeconomics & Outcomes Research|September 30, 2014
Biological therapies in Crohn's disease: are they cost-effective? A critical appraisal of model-based analysesMonia Marchetti, Nicola Lucio Liberato
Expert Review of Pharmacoeconomics & Outcomes Research|January 29, 2016
Cost-effectiveness of non-vitamin K antagonist oral anticoagulants for stroke prevention in non-valvular atrial fibrillation: a systematic and qualitative reviewNicola Lucio Liberato, Monia Marchetti
Clinical Therapeutics|November 9, 2004
Cost utility and budget impact of third-generation aromatase inhibitors for advanced breast cancer: a literature-based model analysis of costs in the Italian National Health ServiceMonia Marchetti, Mauro Caruggi, Giorgio Colombo
Drugs & Aging|July 2, 2003
Clinical and economic issues in the treatment of advanced breast cancer with bisphosphonatesNicola Lucio Liberato, Monia Marchetti, Giovanni Barosi
Mediterranean Journal of Hematology and Infectious Diseases|May 19, 2021
Cost-Effectiveness of Post-Autotransplant Lenalidomide in Persons with Multiple MyelomaMonia Marchetti, Robert Peter Gale, Giovanni Barosi
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Cost minimization of on-demand maintenance therapy with proton pump inhibitors in nonerosive gastroesophageal reflux diseaseDyfrig A Hughes, Monia Marchetti, Giorgio Colombo
Pageof 13